BrainSpace Secures FDA 510(k) Clearance for Intellidrop, Advancing Automated Brain Fluid Management and Data-Driven Neuro Care

New updates have been reported about brainspace.

BrainSpace has received U.S. FDA 510(k) clearance for Intellidrop, its automated brain fluid management system designed to continuously monitor intracranial pressure and deliver precision, closed-loop cerebrospinal fluid (CSF) drainage to individualized pressure or volume targets. The system combines proprietary hardware and software to automate external CSF management in ventricular or lumbar applications, directly addressing ICU workflow pressures and nursing shortages in the care of patients with traumatic brain injury, stroke, skull base tumor surgeries, and neurodegenerative conditions such as normal pressure hydrocephalus. CEO and co-founder Caitlin Morse noted that the clearance converts long-standing demand from ICU nurses into a deployable solution across U.S. hospitals, potentially improving both staff efficiency and patient experience.

The authorization positions BrainSpace at the center of an emerging category of Brain Fluid Interface (BFI) technologies that measure, monitor, and act on brain fluids including CSF, interstitial fluid, and cerebral blood, providing a continuous view into brain health. Intellidrop generates multimodal, contextualized data that the company intends to use to train Physical AI models, creating a data asset that may underpin future predictive and personalized neuro-care solutions. Against a backdrop where an estimated one in three people globally will experience a neuro injury, illness, or degeneration in their lifetime, BrainSpace is targeting a large and growing clinical and economic burden with tools that aim to simplify hospital workflows and enable more personalized interventions. Founded in 2021 and already recognized by several medtech and investment conferences, BrainSpace now moves from development to commercial readiness in the U.S., with the potential to expand adoption as hospitals seek scalable, technology-driven solutions for complex neurocritical care.